Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Investor Presentation (November 2025)
46 slides from Zota Health Care's investor presentation, Nov 6, 2025
Slide 1: Regulation 30 filing cover letter to NSE
November 06, 2025 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirem
Slide 2: Investor Presentation
Investor Presentation Zota Health Care Limited
Slide 3: Safe Harbour
This presentation has been prepared by the Zota Health Care Limited (the “Company”) Safe Harbour only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe to the securities of the Company. No offering of securities shall be made except by means of off
Slide 4: Company Overview
healthcare Itd. Company Overview A zota healthcare Itd.
Slide 5: Zota Health Care Limited At a Glance
Zota Health Care Limited At a Glance Financial Highlights (FY25 - Consolidated) Zota Health Care Limited a publicly Headquartered in Surat, Davaindia, launched in October 2017, listed company on NSE, has Gujarat. is a retail generic pharmacy chain that established a significant footprint in provides
Slide 6: Our Journey
Our Journey Foundational Steps In Setting Up Formulations Domestic Marketing Export Business Strengthening Core And Pioneering Davaindia 2000 2004 2010 2011 2017 2018 Zota Health Care - Acquired all brand Inaugurated an export- Commenced exports, Introduced Davaindia, a Achieved ₹10+ Cr in Export Sa
Slide 7: Management Profile
Management Profile K e t a nku ma r C h a n d ul al Z o t a M o x e s h K e t a nb hai Z o t a D r. S uj i t P a u l Chairman and Non-Executive Director Managing Director Group Chief Executive Officer H i m a n s hu M u k t i l a l Z o t a K a m l e s h R a j a ni k a nt Z o t a Vi r e n M a n uk a
Slide 8: Company's Business Structure
Company’s Business Structure Step down subsidiary Supplying products at ALP* Davaindia Zota Health Care Limited (Listed entity) (Davaindia Health Mart Limited) Procurement in listed entity FOFO Domestic COCO Export (Sales to FOFO# stores) Marketing Operations (COCO# stores) Business FOFO Sales throu
Slide 9: Business Overview & Industry Dynamics
Business Overview & Industry Dynamics 8
Slide 10: Business Verticals
Business Verticals DAVAINDIA Revenue contribution (H1FY26) A Retail generic pharmacy chain providing quality generic medicines. • • Focuses only on private-label products in:Nutraceutical Formulations 02 Store variants 30% – 90% Company-Owned and Company- Savings on medicines as Everyday Herbal Grou
Slide 11: Pharmacy Retail is a High Growth Opportunity within the Indian Retail Market
Pharmacy Retail is a High Growth Opportunity within the Indian Retail Market Indian Pharmacy Retail constitutes a large and Operational Efficiency and Better Unit Economics drive Organized expanding market opportunity Pharmacy retail ahead of its Peers (INR Billion) 4,793 Retail Food & Food Services
Slide 12: Positioned to Capitalize on Growth in Organized Pharmacy Retail
Zota Health Care Limited is strategically positioned to capitalize on the growth opportunities in Organized Pharmacy Retail Organized Pharmacy Retail (by value) continues to Gain Momentum Growth Drivers for Organized Pharmacy Retail Pharmacy Retail (Organised) Pharmacy Retail (Unorganised) 1 Rising
Slide 13: One of the Leading players in Pharmacy Retail Market in India
Zota Health Care Limited | One of the Leading players in Pharmacy Retail Market in India Share of Key Players in Modern B&M Pharmacy Outlets Zota Health Care Limited is the third largest Private Pharmacy Retailer in (FY25) India (by number of stores) as of FY25 No. of Stores (FY25)(1) 0.5% 15.3% PMJ
Slide 14: Key Strengths
Zota Health Care Limited | Key Strengths Exclusive focus on private label products in Davaindia Wide product range with manufacturing tie-up Pan-India customer reach and global presence Efficient supply chain management Strengths Focused marketing activities to help achieve faster store maturity Emp
Slide 15: Davaindia
dj davaindia’ GENERIC PHARMACY | x | \ | DAVAINDIA
Slide 16: Davaindia - Retail Pharmacy Chain data
Davaindia - Retail Pharmacy Chain data Revolutionizing the generic pharmacy industry with affordable, accessible, quality healthcare solutions through a chain of retail pharmacies 2000+ 2,055* 1,207* 848* Total no. COCO stores FOFO Stores SKUs of stores • Launched in October 2017, Davaindia has rapi
Slide 17: Davaindia - Operating Model
Davaindia - Operating Model Davaindia Health Mart Limited has Offers a cluster-based store 2,000+ SKUs with 70% medicinal Cloud-based software and AI- implemented a hyperlocal e-commerce model model, optimizing accessibility products and 30% OTC products, with based tools for real-time supply for on
Slide 18: Davaindia - Eliminating traditional supply chain
Davaindia - Eliminating traditional supply chain By sourcing directly from manufacturers and selling straight to consumers, traditional pharma supply chain is eliminated & the cost benefits are transferred to the consumer Cost benefit to End Doctors Consumers ~30-90% savings Traditional on Davaindia
Slide 19: Case Study – Savings on Davaindia's margins
Case Study – Savings on Davaindia’s margins Company marketed by Indian MNC 1 Indian MNC 2 Davaindia Tablet Rosuvas 10 mg Rosubest 10 Rosuvastatin 10 Molecule Rosuvastatin 10mg Generic Type Branded Generic Trade Generic Generic (Private Label) MRP (INR) 345.5 119 23 Telmisartan 40 mg & Aceclofenac 10
Slide 20: Davaindia – What are COCO Stores
Davaindia – What are COCO Stores COCO stores are modern walk-in stores providing a distinct contrast to traditional counter-based pharmacies enhancing customer satisfaction and loyalty. Expansion & growth Number of COCO stores has grown from 101 stores in FY23 to 1,207 stores in H1FY26 (till Septemb
Slide 21: Davaindia – COCO Stores
Davaindia – COCO Stores 20
Slide 22: Davaindia - COCO Stores
Davaindia - COCO Stores Company-Owned Company-Operated 1,207 States No. of Stores Operational West Bengal Operated by wholly-owned 388 subsidiary 12 COCO stores Uttar Pradesh Davaindia Health 229Mart Ltd 22 51 Maharashtra 116 64 Enhancing Store Delhi 87 87 Economics Haryana 64 229 Kerala 63 47 Uttar
Slide 23: Davaindia COCO - KPIs (1/2)
Davaindia COCO - KPIs (1/2) No. of Stores Footfall ₹ in lakhs 55.10 1,207 52.60 852 20.70 253 7.75 101 FY23 FY24 FY25 H1FY26 FY23 FY24 FY25 H1FY26 H1FY26 As of September 30 ,2025 22
Slide 24: Davaindia COCO - KPIs (2/2)
Davaindia COCO - KPIs (2/2) GMV ₹ in lakhs Average Wallet Spend ₹ in Lakhs ₹ 12,568 ₹ 245 ₹ 12,070 ₹ 229 ₹ 229 ₹ 5,063 ₹ 212 ₹ 1,645 FY23 FY24 FY25 H1FY26 FY23 FY24 FY25 H1FY26 H1FY26 As of September 30 ,2025 23
Slide 25: Davaindia – What are FOFO Stores
Davaindia – What are FOFO Stores Franchisee-Owned Franchisee-Operated Asset-light franchise model (FOFO) FOFO stores employ an asset-light franchise operated model. Smaller Store size FOFO stores are compact and over-the-counter format stores, typically having an average size of about 200-300 sq.ft.
Slide 26: Davaindia - FOFO Stores
Davaindia - FOFO Stores States No. of Stores Uttar Pradesh 167 West Bengal 164 13 Odisha 112 Madhya Pradesh 65 2 6 Gujarat 57 12 Maharashtra 43 42 3 Haryana 42 30 1 Delhi 30 28 9 Rajasthan 28 848 167 26 Bihar 26 Kerala 16 15 Tripura 15 57 65 9 164 Operational FOFO stores Jammu & Kashmir 13 Uttarakha
Slide 27: Davaindia FOFO - KPIs (1/2)
Davaindia FOFO - KPIs (1/2) No. of Stores Footfall ₹ in lakhs 848 42.5 730 627 31.0 26.3 493 24.4 FY23 FY24 FY25 H1FY26 FY23 FY24 FY25 H1FY26 H1FY26 As of September 30 ,2025 26
Slide 28: Davaindia FOFO - KPIs (2/2)
Davaindia FOFO - KPIs (2/2) GMV ₹ in lakhs Average Wallet Spend ₹ in lakhs ₹ 11,994 ₹ 282 ₹ 282 ₹ 281 ₹ 8,703 ₹ 7,411 ₹ 6,739 ₹ 276 FY23 FY24 FY25 H1FY26 FY23 FY24 FY25 H1FY26 H1FY26 As of September 30 ,2025 27
Slide 29: OTC (Over-the-counter) products
OTC (Over-the-counter) products Acquired 65.98% stake in the Everyday Herbal Beauty Strategic Acquisition as a Care Private Limited & 56% in Everyday Herbal Beauty move towards backward and Wellness Care Private Limited, licensed by the Khadi integration and Village Industrial Commission, a strategi
Slide 30: OTC – Products
OTC – Products 29
Slide 31: Davaindia – Making Quality Healthcare, Affordable and More Accessible Across India
Davaindia – Making Quality Healthcare, Affordable and More Accessible Across India ₹19,481 lakhs Gross Merchandise Value (GMV) in H1FY26 ~60 % Gross Margin in COCO format COCO GMV – ₹12,070 lakhs FOFO GMV - ₹7,411 lakhs 2,055 30-90 % Savings to consumers on Fast growing FOFO & Generic medicines COCO
Slide 32: State-Wise Presence of Davaindia Across India
State-Wise Presence of Davaindia Across India (COCO & FOFO Models) States COCO FOFO Total West Bengal 388 164 552 Uttar Pradesh 229 167 396 Maharashtra 116 43 159 Delhi 87 30 117 Odisha 2 112 114 Haryana 64 42 106 Gujarat 29 57 86 Madhya Pradesh 14 65 79 Kerala 63 16 79 Rajasthan 47 28 75 Uttarakhan
Slide 33: Davaindia's Competitive Edge
Davaindia’s Competitive Edge The Main Focus of Davaindia: Affordable, Trustworthy, and Innovative Pharmacy Solutions BENEFITS TO THE CUSTOMERS BENEFITS TO THE PARTNERS Medicines priced at low MRP thereby ensuring affordability for the masses Store operations and the supply chain efficiently managed
Slide 34: 82% Repeat Customers
Healthy Repeats Total Average (in %) With a strong base of 82% repeat customers, Davaindia demonstrates a high level of customer satisfaction 82% and loyalty. Repeat Customers 33
Slide 35: Higher Chronic category share
Higher Click toChronic edit Master category title share style CATEGORY MIX FY25 CATEGORY MIX H1FY26* 57% 60% 27% 27% 16% 13% Chronic OTC Others Chronic OTC Others Higher chronic share: More than 50% of our revenue comes from chronic disease category, signalling high realization and retention rates,
Slide 36: Supply Chain Management
Click Supply to edit ChainMaster Management title style • The Company has outsourced supply chain management to a third-party warehousing & logistics partner. • A state-of-art central warehousing & processing center has been built in Surat. 35
Slide 37: Domestic Marketing Business
Domestic Marketing Business 36
Slide 38: Domestic Marketing Business
Domestic Marketing Business Marketing Value Chain: This business vertical distributes generic drugs, OTC Finished Dosage Form products, and other pharmaceutical products through the Manufacturers WHO-GMP certified Company’s distribution network spread across India. manufacturing partners Distributio
Slide 39: Export Operations
healthcare Itd. Export Operations A zota healthcare Itd.
Slide 40: Export Operations
Export Operations Dossiers Registered In Global Markets Our Exports business vertical, which started in 2011, serves 1. Benin 15. Sri Lanka clients in over 30 countries, mainly in the CIS, Latin America, 2. Bolivia 16. Swaziland Africa, and Asia. At its plant in Sachin, SEZ, the Company 3. Cambodia
Slide 41: Zota Health Care Limited | Key Strategies
Zota Health Care Limited | Key Strategies Expansion of Davaindia footprint with a focus on COCO model • Continued expansion using a cluster-based saturation strategy • Increase presence in highly dense residential areas in larger cities Continue marketing and brand building activities • Undertake mu
Slide 42: Financial Overview
healthcare Itd. Financial Overview A zota healthcare Itd.
Slide 43: Annually Financial Snapshot
Annually Financial Snapshot Davaindia ₹ lakhs Domestic Marketing Business ₹ lakhs Export Operations ₹ lakhs 18,621.00 3,190.00 6,342.48 17,122.00 5,949.49 5,688.33 2,466.75 2,004.52 10,356.00 1,759.00 3,297.08 5,578.00 FY23 FY24 FY25 H1FY26 FY23 FY24 FY25 H1FY26 FY23 FY24 FY25 H1FY26 Davaindia has d
Slide 44: Profit & Loss Statement (Consolidated)
Profit & Loss Statement (Consolidated) ₹ in lakhs (Consolidated) Particulars H1FY26 FY25 Export Operations 1,759.06 3,190.34 Davaindia Sales 17,121.49 18,621.40 Domestic Marketing Business 3,297.37 6,341.50 Everyday Herbal Group 1,075.16 1,144.22 Revenues from Operations 23,253.08 29,297.46 Cost of
Slide 45: Balance Sheet Statement (Consolidated)
Balance Sheet Statement (Consolidated) ₹ in lakhs (Consolidated) As at As at As at As at Assets Equity and Liabilities 30th September 2025 31st March 2025 30th September 2025 31st March 2025 Non-Current Assets (i) Equity Share capital 3,064.38 2,863.50 Property, plant and equipment 7,593.49 5,598.94
Slide 46: Thank You
Thank You "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002, Gujarat, India cszota@zotahealthcare.com www.zotahealthcare.com 45
Zota Health Care — Investor Presentation (November 2025) on 6ix